Irritable Bowel Syndrome News

VANCOUVER, British Columbia — ChatGPT 4.0 had an overall accuracy of 80% in its answers to questions about irritable bowel syndrome, although the chatbot still missed some details or provided outdated information, according to research.

VANCOUVER, British Columbia — Continued Ibsrela therapy for 12 weeks enabled early nonresponders with irritable bowel syndrome and constipation to achieve a meaningful response, noted a presenter at the ACG Annual Scientific Meeting.

Titrated low-dose amitriptyline demonstrated effectiveness and tolerability as a second-line therapy for irritable bowel syndrome in primary care compared with placebo, a randomized study in the United Kingdom showed.

An app-based digital therapeutic was “largely effective” in reducing symptoms and improving quality of life, work productivity and health literacy among patients with irritable bowel syndrome, according to late-breaking data from UEG Week.

Case-control and cohort analyses showed dysphasia, gastroparesis, irritable bowel syndrome without diarrhea and constipation may be associated with an increased risk for Parkinson’s disease, according to research in Gut.

Children and adults with atopic dermatitis are at an increased risk for inflammatory bowel disease, ulcerative colitis and Chron’s disease, according to a study.

A nationwide survey of nearly 89,000 individuals estimated the prevalence of Rome IV irritable bowel syndrome in the U.S. to be 6.1% compared with 4.7% to 5.3% in previous reports, according to a cross-sectional study in Gastroenterology.

In this month’s issue, we are highlighting the important topic of multidisciplinary care of our gastroenterology patients.

From the impact of Humira biosimilars flooding the U.S. market to shifting trends in colorectal cancer demographics, Healio has asked experts the big questions to stay abreast of the current hot topics in gastroenterology and hepatology.

In this podcast episode, Tamara Duker Freuman, MS, RD, CDN, discusses how the work of gastroenterologists and dieticians can inform each other, approaching GI conditions as new science emerges and more.